[Early onset of methotrexate-associated lymphoproliferative disorder mimicking Hodgkin's lymphoma].

Hautarzt

Klinik und Poliklinik für Dermatologie und Venerologie, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland.

Published: January 2022

Long-term methotrexate (MTX) treatment is known to cause MTX-associated lymphoproliferative disorder (MTX-LPD). A 58-year-old woman with psoriasis vulgaris and pityriasis rubra pilaris was treated with a combination of MTX and ustekinumab for 4 months when she developed generalized lymphadenopathy. The initial histopathological analysis indicated Hodgkin's lymphoma; however, assessing the patient's clinical history revealed the diagnosis of MTX-LPD. To our knowledge, this is the first case of a MTX-LPD after only 4 months of treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755694PMC
http://dx.doi.org/10.1007/s00105-021-04804-6DOI Listing

Publication Analysis

Top Keywords

lymphoproliferative disorder
8
[early onset
4
onset methotrexate-associated
4
methotrexate-associated lymphoproliferative
4
disorder mimicking
4
mimicking hodgkin's
4
hodgkin's lymphoma]
4
lymphoma] long-term
4
long-term methotrexate
4
methotrexate mtx
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!